Research map: Letter: Defining the Incremental Predictive Value of HBsAg in Hepatocellular Carcinoma Risk Prediction

Back to the article

Papers in this map

  1. Decision Curve Analysis: A Novel Method for Evaluating Prediction Models · Andrew Julian Vickers · 2006 · 6232 citations · Cited by this paper
  2. Letter: Defining the Incremental Predictive Value of HBsAg in Hepatocellular Carcinoma Risk Prediction, Authors' Reply · Yi‐Fan Guo · 2026 · Cites this paper
  3. Review Article: Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine · 2026 · Related
  4. Assessing the Performance of Prediction Models · Ewout Willem Steyerberg · 2009 · 5185 citations · Cited by this paper
  5. Letter: External Validation of Hepcidin Thresholds for Predicting Response to Iron Therapy in Active Inflammatory Bowel Disease · 2026 · Related
  6. Dichotomizing continuous predictors in multiple regression: a bad idea · Patrick J Royston · 2005 · 2321 citations · Cited by this paper
  7. Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma · 2026 · Related
  8. Interpreting Incremental Value of Markers Added to Risk Prediction Models · Michael J. Pencina · 2012 · 518 citations · Cited by this paper
  9. Natural History of Recurrent Acute Pancreatitis: Implications for Interventional Trial Design · 2026 · Related
  10. HBsAg Quantification‐Based Models for Predicting Hepatocellular Carcinoma Risk in Nucleos(t)ide Analogs‐Experienced Patients With Chronic Hepatitis B: The HBsAg ‐ HCC Score · Yi‐Fan Guo · 2026 · 4 citations · Cited by this paper
  11. Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety · 2026 · Related
  12. Letter: Does the Association Between Mild Endoscopic Activity and Adverse Outcomes Justify Treatment Escalation in Older Adults With Inflammatory Bowel Disease? · 2026 · Related
  13. Eosinophilic Oesophagitis Beyond the Oesophagus: High Prevalence of Chronic Rhinosinusitis‐Type Symptoms and Their Impact on Symptom Severity in Swiss EoE Cohort Study Patients · 2026 · Related
  14. Non‐Selective Beta‐Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation · 2026 · Related
  15. Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction‐Associated Steatohepatitis—Reanalysis of Fibrosis Stage 2–3 Subset · 2026 · Related

Source: OpenAlex (CC0)